Successful treatment of extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis with MEDA chemotherapy

Leuk Lymphoma. 2017 May;58(5):1238-1241. doi: 10.1080/10428194.2016.1228931. Epub 2016 Sep 23.

Authors

Da-Hui Li¹, Xiao-Yan Zhang², Chao Du³, Wen-Hao Zhang¹, Jun Chang¹, Yu-Jie Ma¹, Zhi-Chao Li¹, Si-Guo Hao¹, Hao Ding⁴, Rong Tao¹

Affiliations

¹ a Department of Hematology, Xin Hua Hospital , Shanghai Jiao Tong University School of Medicine , Shanghai , China.
² b Department of Hematology , Xin Jiang People's Hospital , Xin Jiang , China.
³ c Department of Hematology, Tong Ren Hospital , Shanghai Jiao Tong University School of Medicine , Shanghai , China.
⁴ d Department of Radiation Oncology , Eye and ENT Hospital of Fudan University , Shanghai , China.

PMID: 27658861
DOI: 10.1080/10428194.2016.1228931

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Female
Humans
Lymphohistiocytosis, Hemophagocytic / diagnosis
Lymphohistiocytosis, Hemophagocytic / drug therapy*
Lymphohistiocytosis, Hemophagocytic / etiology*
Lymphohistiocytosis, Hemophagocytic / mortality
Lymphoma, Extranodal NK-T-Cell / complications*
Lymphoma, Extranodal NK-T-Cell / diagnosis
Male
Middle Aged
Prognosis
Retreatment
Treatment Outcome